Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|HER2 Positive|First or Second Line Therapy|Failure or Contraindication of Trastuzumab Therapy
Interventions: DRUG: Lapatinib and Capecitabine and Vinorelbine
Sponsor: Sponsor GmbH
Collaborators: iOMEDICO AG|Arbeitsgemeinschaft fur Internistische Onkologie|Arbeitskreis Klinische Studien|GlaxoSmithKline